6WA0
De novo designed receptor transmembrane domains enhance CAR-T cytotoxicity and attenuate cytokine release
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
| Synchrotron site | Australian Synchrotron |
| Beamline | MX2 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2019-11-22 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.9537 |
| Spacegroup name | P 32 2 1 |
| Unit cell lengths | 96.159, 96.159, 79.299 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 41.638 - 3.484 |
| R-factor | 0.2238 |
| Rwork | 0.220 |
| R-free | 0.25900 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 5eh6 |
| Data reduction software | XDS (Mar 15, 2019 BUILT=20190315) |
| Data scaling software | Aimless (0.7.4) |
| Phasing software | PHASER (2.8.2) |
| Refinement software | PHENIX (1.16_3549) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 48.080 | 48.080 | 3.560 |
| High resolution limit [Å] | 3.300 | 8.720 | 3.300 |
| Rmerge | 0.164 | 0.039 | 2.044 |
| Rmeas | 0.172 | 0.041 | 2.148 |
| Rpim | 0.054 | 0.014 | 0.656 |
| Total number of observations | 67364 | 3568 | 14143 |
| Number of reflections | 6676 | 404 | 1354 |
| <I/σ(I)> | 10.7 | 40.5 | 1.3 |
| Completeness [%] | 100.0 | 99.5 | 100 |
| Redundancy | 10.1 | 8.8 | 10.4 |
| CC(1/2) | 0.999 | 0.999 | 0.544 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8 | 293 | 10 mg/ml peptide in 30mM C8E4 65 v/v 2-methyl-2,4-pentanediol 0.1 M tris chloride pH 8 |






